Adrian S. Hill-V S Hill
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Identification of cross-stage, cross-species malaria CD8+ T cell antigens.
Journal: Nature
Published: May 16, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Journal: The Lancet. Microbe
Published: October 05, 2023
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.
Journal: Vaccines
Published: March 11, 2019
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.
Journal: Diseases (Basel, Switzerland)
Published: September 28, 2018
Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.
Journal: Vaccines
Published: June 25, 2018
Prime and target immunization protects against liver-stage malaria in mice.
Journal: Science translational medicine
Published: September 08, 2017
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4.
Journal: Nature communications
Published: January 25, 2017
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.
Journal: Vaccines
Published: June 07, 2016
Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women.
Journal: BMC infectious diseases
Published: August 13, 2015
Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine.
Journal: Vaccine
Published: November 18, 2014
Last Updated: 09/26/2026